HLA-B and infection: NQK-Q8 was previously identified as immunodominant28, and these authors also demonstrated that NQK-Q8-specific T cells from HLA-B*15:01+ patients with infection were cross-reactive to the highly homologous peptide NQKLIANAF (hereafter, NQK-A8) from the seasonal coronaviruses HKU1-CoV and OC43-CoV.